Precision Optics Corporation, Inc. (NASDAQ:POCI) Q2 2023 Earnings Call Transcript

Page 5 of 5

Dr. Joe Forkey: No, I understand exactly what you’re saying, I think. Let me give it a try. You can steer me in the right direction if I miss it. So there’s really two questions there, I think, there are two parts to this question. The first one is whether these companies are cannibalizing their existing market and moving from a reusable device to a single-use device. And for the larger companies that we’re working with, which, by and large, are the ones we’re working with now for our single-use — the single-use programs we have now, that is true. That is the case. When we look at the single-use market in general, one of the reasons that we see it growing faster than the medical device market in general, is because it’s not only growing with new procedures, but it’s also growing by replacing reusable devices with single-use devices.

I would say, though, sort of across the board, whenever a customer comes to us with a new product, one of the questions they’re always asking is, can it be single-use? And so it depends then on the configuration of the system and all the rest. So the answer to the first part is, it is true that our customers today are replacing their reusable device with a single-use device. We really like that, by the way, because it means that they already have an established market. They already have a brand name. So we see that as lowering the risk to the overall success of the program. In terms of our negotiations with regard to maintaining ownership of the technology, the technology that we’re bringing to the partnership, of course, is the technology that relates to the design and manufacture of the optics in the imaging system in a way that can be manufactured at low cost with high quality.

And that — those technologies are technologies that cut across lots of different disciplines. So while it’s true that our customers may already have some technology, some IP in sort of the particular procedure they’re going to use the product for, the technology that’s embedded in the single-useness, if you like, of the system and then the imaging system really still belongs to us and really comes from our expertise, that after all is why they’ve come and engaged with us. And so it’s — in all cases, we have to have a negotiation. But I wouldn’t say that it’s more challenging in these cases than it has been in other cases because, again, the reason they’re coming to us is because we have capabilities and technology that other companies don’t and that they don’t have.

And so that gives us a significant leverage in being able to negotiate a fair and beneficial — technology agreement that’s beneficial to POC.

Operator: This concludes our question-and-answer session. I would like to turn the conference back over to management for any closing remarks.

Dr. Joe Forkey: Thank you, Gary, and thank you all for joining us today on the call. I look forward to speaking with you all soon. Have a good evening.

Operator: The conference has now concluded. Thank you for attending today’s presentation. You may now disconnect.

Follow Precision Optics Corporation Inc. (OTCMKTS:POCI)

Page 5 of 5